Public awareness of pervasive developmental disorders (PDDs), including autistic disorder (autism), has been increasing. In parallel, results from research directed toward pharmacologic treatment of interfering symptoms associated with PDDs has escalated. This review will focus on controlled drug studies performed to treat the interfering symptoms of PDDs. These include hyperactivity/inattention, repetitive and stereotypic behavior, irritability (aggression, self-injury, severe tantrums) and core social impairment. A priority is placed on randomized, placebo-controlled trials when available. The side effects of the medications in this population are also discussed.
ASJC Scopus subject areas
- Psychiatry and Mental health